
Deep tech venture fund backing patent-based science startups in the US Southwest and Northern Europe

Boston venture fund making early-stage investments in founders chosen for emotional intelligence

EQx Fund is an early-stage venture capital fund headquartered in Boston, Massachusetts. Founded in January 2018, it invests in serial and first-time entrepreneurs at the pre-seed to Series A stages, across technology, life sciences and consumer sectors. Its stated mantra is to invest in people for a better world, and it builds a portfolio of founders it describes as EQx founders.
The fund uses emotional quotient, meaning how well a person understands others, works with them and inspires them, as a central measure of a founder. Its ideal investment candidate, the EQx founder, has seven important characteristics that help an idea grow into a successful company. The fund says leadership and passion are key, and that it looks for industry disruptors and high growth opportunities.
The fund works in partnership with Boston Harbor Angels, which it describes as one of the top three angel groups in the United States. Its partners bring investment and operating experience gained in the United States and abroad, and the fund invests only in companies and founders that all partners vote unanimously to back. Deals come through an extensive network of partners and entrepreneurs.
The fund says it invests in gender, ethnic and cultural diverse leaders on purpose, because its own team comes from varied backgrounds. In its first fund, nearly forty percent of investments went to female founders. The fund says that figure is well above the venture capital industry average, and that it knows more work is needed.
The fund says its founders are working on problems from student debt to cheaper and faster cloud storage for enterprises, and from stem cell engineering to type 1 diabetes. Named portfolio companies include Wasabi, a cloud storage company that has raised a large growth round, and Immusoft, a Seattle-based cell therapy company that is developing a modified B cell approach to treating disease.
EQx Fund is a Boston-based venture capital fund that backs early-stage companies. It puts people first and picks founders using a profile it calls the EQx founder, based on emotional intelligence, meaning the ability to understand, cooperate with and motivate others.
The fund was set up in January 2018 to invest early in entrepreneurs building biotechnology and other technology companies.
The fund backs first-time and serial entrepreneurs and says it values diverse teams. It reports that nearly forty percent of investments from its first fund went to female founders.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
EQx Fund is ranked on 2 TrustList rankings: #5 on 1 and #8 on 1.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. EQx Fund has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is the only one of the 23 here listing grant and inc.
Its profile: “Named portfolio companies include Wasabi, a cloud storage company that has raised a large growth round, and Immusoft, a Seattle-based cell therapy company that is developing a modified B cell approach to treating disease.”
Of the 23 here, 7 also cover series and 5 also cover biotech; 8 also work in San Francisco and 6 also work in Boston.
Behind Founders' Co-op.
It is the only one of the 54 here listing DataBase and progressive.
Of the 54 here, 29 also cover series a and 21 also cover seed stage; 8 also work in London and 6 also work in Silicon Valley.
Behind Sustainable Conversion Ventures.
As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
No questions yet. Be the first to ask about EQx Fund.
Similar listings buyers compare against this one.

Deep tech venture fund backing patent-based science startups in the US Southwest and Northern Europe

Small venture firm that works closely with early-stage founders from the earliest stage

Healthcare venture capital firm investing in therapeutics and discovery platforms for unmet medical needs

Venture capital firm investing in climate tech, biotech, aerospace and next-generation computing companies

Early-stage venture firm investing in enterprise software companies across the western United States

Venture fund investing in cryptocurrency and blockchain startups, formed with a Southeast Asia venture firm

An early-stage investor focused on digital health, wellness and remote patient monitoring

Global venture capital partnership investing in data, technology and analytics companies, backed by RELX Group
Everything here links back to the same verified catalogue. Pick your next stop.